Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Comparison of ESBL – And AmpC Producing Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated from Migratory and Resident Population of Rooks (Corvus frugilegus) in Austria

  • Igor Loncaric ,

    Contributed equally to this work with: Igor Loncaric, Gabrielle L. Stalder

    igor.loncaric@vetmeduni.ac.at

    Affiliation Unit of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, University of Veterinary Medicine Vienna, Austria

  • Gabrielle L. Stalder ,

    Contributed equally to this work with: Igor Loncaric, Gabrielle L. Stalder

    Affiliation Research Institute of Wildlife Ecology, Dept. of Integrative Biology and Evolution, University of Veterinary Medicine Vienna, Austria

  • Kemal Mehinagic,

    Affiliation Unit of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, University of Veterinary Medicine Vienna, Austria

  • Renate Rosengarten,

    Affiliation Unit of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, University of Veterinary Medicine Vienna, Austria

  • Franz Hoelzl,

    Affiliation Research Institute of Wildlife Ecology, Dept. of Integrative Biology and Evolution, University of Veterinary Medicine Vienna, Austria

  • Felix Knauer,

    Affiliation Research Institute of Wildlife Ecology, Dept. of Integrative Biology and Evolution, University of Veterinary Medicine Vienna, Austria

  • Chris Walzer

    Affiliation Research Institute of Wildlife Ecology, Dept. of Integrative Biology and Evolution, University of Veterinary Medicine Vienna, Austria

Comparison of ESBL – And AmpC Producing Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated from Migratory and Resident Population of Rooks (Corvus frugilegus) in Austria

  • Igor Loncaric, 
  • Gabrielle L. Stalder, 
  • Kemal Mehinagic, 
  • Renate Rosengarten, 
  • Franz Hoelzl, 
  • Felix Knauer, 
  • Chris Walzer
PLOS
x

Abstract

In order to test whether rooks (Corvus frugilegus) represent good indicators for the potential circulation of antibiotics in their native habitat, two populations with different migratory behavior were tested for the presence of beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA). In all, 54 and 102 samples of fresh feces of a migratory and a resident population were investigated. A total of 24 and 3 cefotaxime-resistant enterobacterial isolates were obtained from the migratory and resident population, respectively. In these isolates CTX-M-1 (n = 15), CTX-M-3 (n = 3), and CTX-M-15 (n = 3) genes were detected. TEM-1 and OXA-1 were associated with CTX-M in 3 and 2 isolates, respectively. In two E. coli isolates CMY-2 could be detected, where from one isolate displayed an overexpression of chromosomal AmpC as well. Among E. coli isolates the most common phylogenetic group was A (n = 11) and ST1683 (n = 5). In one E. coli of B2-ST131 the rfbO25b locus was detected. Three Enterobacter isolates were stably derepressed AmpC-producers. In five samples of the migratory population, PVL positive MRSA could be isolated. Two isolates were typed SCCmec IVa, spa type t127, and ST1. Three isolates carried a SCCmec type IVc, with spa type t852 and ST22. The highly significant difference of the occurrence of antibiotic resistance between the migratory population from eastern Europe compared to resident population in our study indicates that rooks may be good indicator species for the evaluation of environmental contamination with antibiotic resistant bacteria, especially due to their ecology, foraging behavior and differing migratory behavior.

Introduction

Antibiotic resistance in bacteria of animal origin and its zoonotic potential has elucidated considerable attention worldwide. Microorganisms responsible for increased resistance are often those from the group of gram-negative rods, mostly beta (β)-lactamase producing members of the family Enterobacteriaceae. Emergence and dissemination of resistance among Enterobacteriaceae represent a serious threat to public health [1]. Therefore, numerous studies involving these bacteria in humans and domestic animals have been published. However, there is still a scarcity of information on the presence of resistant Enterobacteriaceae isolates in wildlife. Studies on the presence of Escherichia coli (E. coli), especially extended-spectrum β-lactamase producing E. coli (ESBL) are performed to detect antibiotic resistance in populations of wild animals [2]. E. coli is a common inhabitant of the gastrointestinal tract of birds and mammals. It is also found in the environment and can therefore be used as indicator of antimicrobial resistance change [3][4]. To our knowledge there are no reports addressing isolation and characterization of β-lactamase producing Enterobacteriaceae from wildlife in Austria. Nevertheless, in the last years a few sources regarding wildlife resistant enterobacterial isolates from neighboring countries are reported. β-lactamase producing E. coli isolates were found in various mammalian and avian hosts in central Europe [5][12]. Studies addressing the presence of β-lactamase producing members of Enterobacteriaceae other than E. coli in wildlife are scarce [13]. Only few studies report the occurrence of another multi-drug resistant bacterial species: methicillin resistant Staphylococcus aureus (MRSA) in wildlife [14][15]. MRSA, first emerged in 1960s, is currently the most common multidrug-resistant bacteria causing nosocomial infections in Europe [16]. In the last years the transfer of MRSA isolates between animals and humans gained specific attention, especially in the case of MRSA multi locus sequence type (ST) 398 belonging to the clonal complex CC398, which has been the most commonly reported MRSA strain found in association with livestock (livestock-associated (LA)-MRSA) [17]. While studies on MRSA in humans, companion animals and livestock have been widely documented the role of this particular pathogen in wildlife is rarely studied. The emergence of MRSA in wild animals could represent a serious threat to human health, companion animals and livestock. Corvids and gulls feed on garbage in urbanized areas and are considered to be important reservoirs and vectors of resistant isolates in the environment [18]. Due to it's wide distribution and gregarious lifestyle the rook (Corvus frugilegus) is considered a good indicator for the potential circulation of antibiotics in their habitat. The biggest coherent population, comprising 5 to 10 million breeding pairs, is located in Russia [19]. Wintering grounds or resident populations range from the Czech Republic to France, mainly in the vicinity of cities. The objective of the study was to evaluate the occurrence of a) broad-spectrum-β-lactam resistance determinants among Enterobacteriaceae and b) MRSA isolated from feces of rooks (Corvus frugilegus) collected from a small resident Austrian population in Burgenland as well as an eastern European migratory population with wintering grounds in the city of Vienna.

Methods

Ethics Statement

No specific permission was required to non-invasively collect fresh fecal samples from the ground on public land. While the rook is protected in the EU birds directive (79/409/EWG) and in the respective national legislation in Austria this study did not involve a protected species. This field study did not involve any contact or disturbance of actual birds as fresh fecal samples were collected from the ground and tree leaves in public areas used by rooks on a daily basis. No permissions are required for this type of activity.

No animals were used, disturbed or otherwise impacted by this study and therefore no Institutional Animal Care and Use Committee (IACUC) permission was required.

Bacterial isolates.

In March 2013, 54 (1 k–54 k) samples of fresh feces of a migratory population of rooks in the Lobau (lob, 48°10′59.78″N; 16°30′15.03″E) and 102 (55 k–106 k) samples of fresh feces of a resident, non-migratory population in Wulkaprodersdorf (wul, 47°47′18.30″N; 16°29′20.68″E) were collected in sterile tubes and transported directly to the laboratory. Each fecal sample was suspended in 1.5 ml of 0,9% sterile saline. For isolation of Enterobacteriaceae, 200 µl of suspended feces was precultured at 37°C overnight in buffered peptone water (BPW) (Merck, Germany) supplemented with cefotaxime (1 mg/L) and then cultivated at 37°C overnight on MacConkey agar (MCA) (Oxoid, Basingstoke, United Kingdom) supplemented with cefotaxime (1 mg/L), which select for broad-spectrum-cephalosporin-resistant isolates. For MRSA isolation, another 200 µl suspended feces was incubated at 37°C overnight in Trypticase soy broth (TSB) (Becton Dickinson, Heidelberg, Germany) with 6.5% NaCl and then streaked in a BBL™ CHROMagar™ MRSA II (Becton Dickinson, Heidelberg, Germany) and on Columbia CNA Agar with 5% Sheep Blood, Improved II (Becton Dickinson, Heidelberg, Germany) and incubated for at 35°C for 24 h.

After incubation on MCA one colony representing each a distinct colonial morphotype was regrown on the same plate and on Müller Hinton Agar II (Becton Dickinson, Heidelberg, Germany). For detection of members of Enterobacteriaceae standard bacteriological techniques were used. Isolates that were oxidase negative produced acid from glucose by oxidation as well as by fermentation were screened for ESBL production by combination disk tests using cefotaxime and ceftazidime with and without clavulanic acid (Becton Dickinson, Heidelberg, Germany) according to Clinical and Laboratory Standards Institute (CLSI) [20]. Furthermore, a cefoxitin disk (30 mg, Becton Dickinson, Heidelberg, Germany) was added to this test, to detect AmpC phenotypes. All isolates classified as intermediate or resistant using CLSI criteria (≤17 mm) to cefoxitin were suspected to be AmpC. ESBL as well as AmpC phenotype were confirmed by MASTDISCS™ ID AmpC and ESβL test (Mast Diagnostics, Merseyside, UK) and were subjected to further characterization. After incubation on BBL™ CHROMagar™ MRSA II the colonies showing typical colony appearance of MRSA were tested on production of β-lactamase using BBL™ DrySlide™ Nitrocefin (Becton Dickinson, Heidelberg, Germany).

Identification of enterobacterial isolates

E. coli-like colonial morphotypes were tested using species specific PCR [21]. For species characterization of other enterobacterial isolates differ in colonial morhphology, 16S rDNA sequence analysis was performed [22]. The isolate was identified using the EzTaxon-e server (http://eztaxon-e.ezbiocloud.net/. Accessed 2013 September 15) [23]. All obtained sequences of have been deposited in the GenBank.

Antimicrobial-susceptibility testing of enterobacterial isolates was performed by the agar disk diffusion method according to CLSI for the following antibiotics: ampicillin, piperacillin, aztreonam, doripenem, ertapenem, imipenem, meropenem, gentamicin, tobramycin, amikacin, tetracyclin, ciprofloxacin, trimethoprim-sulfamethoxazole, chloramphenicol, fosfomycin (all from Becton Dickinson, Heidelberg, Germany). Additionally minimal inhibitory concentration (MIC) was performed by Etest (bioMérieux, Marcy l'Etoile, France) for cefoxitin (AmpC-hyperproducing isolates (stably derepressed only) and ceftazidime, and M.I.C. Evaluator test (Thermo Fisher, Basingstoke, UK) for ciprofloxacin, gentamicin, meropenem and cefotaxime. Escherichia coli ATCC 25922 was used as quality control strains for MIC tests. AmpC-hyperproducing isolates (stably derepressed) of Enterobacter sp. were defined as those with a cefotaxime and ceftazidfime MIC of ≥32 mg/L, without ESBL production and a negative cefoxitin-cefotaxime disk antagonist test [24]. MRSA susceptibility testing were performed as described elsewhere [22].

Determination of genotypic resistance in enterobacterial isolates

Preliminary screening for the presence of blaOXA, blaTEM, blaSHV and blaCTX-M genes in the ESBL-positive isolates was performed by multiplex-PCRs as described earlier [25][26]. The gene that responded positively in the preliminary screening were further analysed by PCR and sequencing using primers as described elsewhere [27][28]. All isolates displaying AmpC phenotypes were tested to detect plasmid mediated AmpC β-lactamases (pAmpC) by multiplex PCR [29] which resulted in a positive amplicon corresponding to enzymes from the CIT group, which were further analyzed by PCR using CMY-F und CMY-R and sequenced as described elsewhere [27]. The sequences obtained were compared to those registered in the GenBank and compared with previously reported sequences for β-lactamases (http://www.lahey.org/studies/ - accessed August 2013). The E. coli isolates displaying AmpC phenotype were also tested for mutations in the chromosomal ampC promoter/attenuator region as described previously [30]. The presence of the genes non- β-lactamase genes tet(A), tet(B), tet(C), tet(D), tet(E), tet(G), cat, cmlA, floR, sul1, sul2, sul3, strA, int1, int2, variable regions of class 1 and class 2 integrons, and gene cassettes dhfr1, dhfr12, dhfr17, aadA1, aadA2, aadA5, estX, and sat1 and sat2 were tested with primers and under conditions as described elsewhere [31]. Isolates resistant to ciprofloxacin were tested for the plasmid-mediated quinolone restance genes, qepA, qnrA, qnrB, qnrC, qnrD, qnrS, and aac(6′)-Ib-cr by PCR [32][36].

Analysis of genetic environment of blaCTX-M

The genetic environment of blaCTX-M genes, such as upstream regions ISEcp1 and IS26 was investigated by PCR and sequencing as previously described [31]. The ISEcp1 region was searched using ISEcp1 5′ primer binding in the 5′ region of ISEcp1 and using ISEcp1 UP primer binding to the transposase gene tnpA of ISEcp1, located in the immediate blaCTX-M upstream region. The presence of IS26 linked to blaCTX-M was tested using tnpA IS26 primer recognizing the transposase gene of the IS26 element.

Conjugations experiments

The transferability of bla genes was carried out by broth mating using a sodium azide-resistant E. coli J53 and sodium azide- and rifampicin resistant E. coli MT 102 as recipients. The strains were grown to the exponential phase and then mixed (1∶2), and the donor and recipient mixture was incubated in Müller-Hintorn (MH) broth overnight at 37°C. Transconjugants were selected on MH agar supplemented with sodium azide (200 mg/L), cefotaxime (1 mg/L), and MH supplemented with sodium azide (150 mg/L), rifampicin (50 mg/L), and cefotaxime (1 mg/L), respectively. Selected transconjugants were further characterized for their antimicrobial susceptibility, presence of the relevant bla genes, and co-transfer of other resistance genes as describe above for the wild isolates.

Plasmid replicon typing

Plasmid DNAs were isolated using the GenElute™ Plasmid Miniprep Kit (Sigma-Aldrich, Vienna, Austria) according to the manufacturer's instructions. The presence of replicons was tested by PCR-based method as described previously [37].

Molecular typing methods

The phylogenetic group of each E. coli isolate was determined by recently described revisited Clermont method [38]. Multilocus sequence typing (MLST) of E. coli isolates was performed as described previously [3]. Allelic profile and sequence type (ST) determinations were carried out according to the E. coli MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli. Accessed 2013 September 15.) scheme. In case of E. coli ST131, allele-specific PCR was performed to identify the O25 clone of E. coli [39]. Clonal diversity of enterobacterial isolates was assessed by enterobacterial repetitive intergenic consensus (ERIC)-PCR as described elsewhere [40].

MRSA characterization

MRSA isolates were confirmed by mecA PCR and further investigated by the PCR [41] targeting Panton-Valentine leukocidin (PVL) genes, staphylococcal cassette chromosome mec (SCCmec) typing using multiplex PCR methods with subsequent subtyping, staphylococcal Protein A (spa) typing, and multiple-locus variable-number tandem repeat analyses (MLVA) using multiplex-PCR [41]. Detection of antibiotic resistance genes [42][43] and detection of pyrogenic exotoxin genes were as described earlier [44]. MLST was carried out by PCR amplification and sequencing of seven housekeeping genes (arcC, aroE, glpF, gmk, pta, tpi, yqiL) as previously described [45]. The allelic profiles and sequence types (ST) were assigned by the MLST web site (http://saureus.mlst.net/. Accessed 2013 September 15.).

Statistical analysis

All statistical analyses were conducted using the statistical software R [46]. To test for differences of the frequencies of antibiotic resistances found in the Lobau population (lob) and the Wulkaprodasdorf population (wul) a poisson model (R function glm) was used (20 resistances). Since there was a clear difference in the frequencies between both populations, subsequently logistic regressions were conducted to post-hoc test every single antibiotic-resistance (156 samples each).

Results

Isolation of cefotaxime resistant isolates, phenotypic resistance in Enterobacteriaceae and species identification

Out of 54 samples, a total of 24 cefotaxime-resistant Enterobactericeae isolates were obtained from the migratory population, and 3 cefotaxime-resistant enterobacterial isolates were obtained from the resident population. 22 isolates displayed ESBL phenotype, and 5 isolates displayed AmpC phenotype, wherefrom three Enterobacter isolates were stably derepressed AmpC-producer. Apart from resistance to amipicillin and piperacillin antibiotics, resistance to tetracycline (85% of the isolates), trimethoprim-sulfamethoxazole (62%) and chloramphenicol (48%) was the most prevalent among isolates obtained from migratory population (Table 1). Three cefotaxime-resistant isolates retrieved from resident population showed phenotypic resistance to amipicillin and piperacillin (58 k, 69 k and 100 k) and tobramycin (isolate 58 k). All of enterobacterial isolates remained susceptible to carbapenems. The MICs of cefotaxime for all isolates ranged from 4 to >256 mg/L, the MIC of ceftazidime from 0.25 to 128 mg/L, the MIC for meropenem from 0.008 to 0.12 mg/L, the MIC for ciprofloxacin from 0.008 to >32 mg/L, and for gentamicin 0.5 and 64 mg/L (Table 1). Using species specific primers 19 isolates from migratory population as well as three from resident population were confirmed as E. coli. The highest 16S rDNA gene sequence similarity observed for the isolate 4.2 k (KF022262) was 99.65% with the type strain of Klebsiella pneumoniae subsp. ozaenae ATCC 11296T (Y17654). Isolates isolate 24 k (KF022261) (99.5%) and 44.1 k (KF022259) (99.1%) showed highest similarity scores with type strain of Enterobacter hormaechei ATCC 49162T (AFHR01000079). Isolate 22.1 k (KF022260) was most closely related with members of Citrobacter youngae group (Citrobacter youngae ATCC 29935T (M59291)).

thumbnail
Table 1. Characterization of Extended-Spectrum-β-Lactamase-Producing, Plasmid-Mediated AmpC β-Lactamase-Producing and derepressed AmpC Enterobacteriaceae isolated from rooks.

https://doi.org/10.1371/journal.pone.0084048.t001

Characterization of genotypic resistance in Enterobacteriaceae

The most prevalent genes in ESBL-producing isolates were those from the blaCTX-M group. In all but one isolate from both rook populations blaCTX-M was detected. The genes blaCTX-M-1, blaCTX-M-3, or blaCTX-M-15 were detected solely in 15, 2, and 1 isolates, respectively. The gene blaCTX-M-1 was detected in combination with blaTEM-1 in 2 isolates, blaCTX-M-15 was detected in combination with blaOXA-1 in one isolate from the resident and in one from the migratory population. The gene blaCTX-M-3 was detected in a Citrobacter isolate as well as in a Klebsiella isolate in combination with blaTEM-1. blaTEM-15 was detected in one E. coli isolate. In one E. coli (47.2 k) isolate displaying AmpC phenotyp the combination of plasmidic AmpC (CMY-2) and overexpression of chromosomal AmpC was detected. Mutations in the promoter and attenuator region of the chromosomal ampC gene from E. coli were found at positions −18 (G→A), −1 (C→T), and +58 (C→T) of the ampC gene of E. coli K12. In one E. coli (33 k) isolate CMY-2 was solely detected. The non-β-lactamase genes strA (n = 14), sul2 (n = 13), and tetB (n = 10) were predominant (Table 1). Class 1 integron was detected in 9 ESBL-producing E. coli isolates. Seven isolates contained an integron, 1.7 kb in size with dfr17-aadA5 cassettes. One isolate contained a 1.7 kb integron with dfr17 cassete, and in one isolate with a 1.7 kb integron none of the cassettes tested could be detected. Even though phenotypic resistance to ciprofloxacin was detected in seven isolates in the wild isolates as well as in some plasmids, none of the plasmid-mediated quinolone resistance genes were detected. Phenotypes and resistance genes, including integrons and gene cassettes, are summarized in Table 1.

Conjugations experiments and plasmid analysis

The transfer of the ESBL and pAmpC producing isolates to sodium azide-resistant E. coli J53 and sodium azide- and rifampicin resistant E. coli MT 102 was demonstrated for all bla positive E. coli isolates. The blaCTX-M-3 of the Citrobacter isolate and blaCTX-M-3/blaTEM-1 of the Klebsiella isolate did not transfer. Resistance to non-β-lactamase genes was also cotransferred in some cases (Table 1). The replicon typing revealed 13 different replicon types. Replicon type F was the most common replicon among the isolates.

Genetic environment of blaCTX-M

PCRs applied different primer combination identified the insertion sequence ISEcp1 in its entirety or partially truncated in 20 isolates (Table 1.). PCR using primer ISEcp1 5′ indicated a ∼1.7 kb amplicon of the entire ISEcp1 in two isolates (2 k and 100 k). 16 isolates contained the transposase gene of the insertion sequence IS26 as analyzed by PCR. As confirmed with sequencing all these isolates showed the presence of IS26 disrupted by ISEcp1. All CTX-M-1-positive isolates had a 48 bp region (W sequence) upstream of the blaCTX-M-1 gene and an additional 32 bp X sequence, as observed in a previous sequence reported in the GenBank database (accession no. AM003904). The CTX-M-15-positive isolates had only the 48 bp W sequence, as previously described (AM040707).

Enterobacterial molecular typing methods

Eleven E. coli isolates belonged to phylogenetic group A, 4 to B1, 2 to B2, 1 to C, 2 to D and one to E. E. coli MLST typing identified 11 different types among the tested isolates (Table 1). Among E. coli isolates, the most commonly identified genotypes were ST1683 (n = 5), ST744 (n = 3), ST34 (n = 2), ST58 (n = 2), ST69 (n = 2), and ST162 (n = 2), whereas isolates belonging to the ST23, ST90, and ST131 genotypes were also identified. The CMY-2 isolate belonged to ST224. One CMY-2 isolate could not be assigned. Allele-specific PCR confirmed the presence of the rfbO25b locus in E. coli of ST131 (phylogenetic group B2) and, showing that it belonged to the O25b type. ERIC-PCR analysis was used to analyze the molecular epidemiology of all enterobacterial isolates and showed that two ST162 (B1) isolates (2 k and 48,1 k), two ST1683 (A) (45,1 k and 53 k), two ST34 (A) (25 k and 39 k), two ST58 (B1) (19 k and 23,2 k), two ST69 (D) isolates from resident population (69 k and 100 k) as well as two derepressed AmpC Enterobacter sp. were clonally related due to identical ERIC fingerprint (data not shown).

MRSA characterization

In five samples of the migratory population, MRSA could be isolated, whereas all fecal samples of the resident population were negative on presence of MRSA. In all five isolates the production of β-lactamase was confirmed using a nitrocefin assay. All isolates were mecA and PVL positive as determined by PCR. Two isolates (3mrsak and 5mrsak) carried a SCCmec type IVa cassette, belonged to spa type t127, and shared the same MLVA genotype. These two isolates carried tet(K) resistance genes as well as seh toxin genes. MLST revealed that these two isolates belonged to sequence type (ST) 1. Other three isolates (39mrsak, 41mrsak, 53mrsak) carried a SCCmec type IVc, with spa type t852 and were indistinguishable after multiplex-PCR MLVA, carried aacA-aphD and msrA resistance genes and sed toxin genes. These isolates were typed by MLST as ST22. Isolates 3mrsak and 5mrsak were resistant to β-lactams and tetracycline, whereas 39mrsak, 41mrsak and 53mrsak were resistant to β-lactams and ciprofloxacin. The MICs of oxacillin for all isolates ranged from 32 to >256 mg/L, the MIC of cefoxitin from 24 to 48 mg/L (Table 2).

thumbnail
Table 2. Characteristics of Methicillin-resistant Staphylococcus aureus (MRSA) isolated from rooks.

https://doi.org/10.1371/journal.pone.0084048.t002

Differences in enterobacterial antibiotic resistance between the two rook populations

A total of 44.4% of the fecal samples (24 of 54) collected in the migrating population showed at least resistance to one of the tested antibiotics compared to 2.9% (3 of 102) in the resident population. As shown in Figure 1 the proportion of antibiotic resistances is significantly (p<0.001) higher in the migrating (lob) population then in the resident (wul) population. Posthoc tests for each tested antibiotic showed significant differences for ampicillin, piperacillin, ceftazidime, cefotaxime, aztreonam and trimethoprim-sulfamethoxazole (Table 3).

thumbnail
Figure 1. Proportion of antibiotic resistance in the two rook populations.

The percentage of antibiotic resistance rates is significantly (p<0.001) higher in the migrating (lob) population then in the resident (wul) population

https://doi.org/10.1371/journal.pone.0084048.g001

thumbnail
Table 3. Differences in the occurrence of antibiotic resistance between the migratory population (lob) and a the resistant population (wul) of rooks.

https://doi.org/10.1371/journal.pone.0084048.t003

Discussion

In the present study, the phenotypic and genotypic characteristics of β-lactamase producing Enterobacteriaceae as well as methicillin resistant Staphylococcus aureus isolates from two different rooks populations were investigated. The isolation rates (44.4%) of cefotaxime resistant enterobacterial isolates was significantly higher in migratory population (2,9%) than in the resident population.

Genotypic characterization of the isolates revealed that the majority of ESBL-E. coli harbored blaCTX-M-1 genes and belonged to six different STs: ST34 (phylogenetic group A), ST58 (B1), ST69 (D), ST162 (B1), ST744 (A and C), and ST1683 (A). CTX-M-1, a major ESBL type in livestock in Europe [47] has also been detected in different wildlife avian host in Europe such as different birds of prey from Portugal, seagulls from Portugal and Sweden, black headed gull from Czech Republic and yellow legged gull from France [6] [48][51]. Very recently the E. coli harboring blaCTX-M-1 and blaTEM-1 belonged to ST744 (A) were isolated from different birds of prey (Milvus migrans, M. milvus and Buteo buteo) in Germany [52]. In our study two E. coli CTX-M-1 clonally related isolates also harbored blaTEM-1 and belonged to ST58. ST58 isolates harboring the same genes were also isolated from seagulls in Portugal [53]. Two CTX-M-1 E. coli isolates retrieved from the resident rook's population belonged to the phylogenetic group D and ST69. This is especially interesting because previous studies have reported the association of E. coli isolates of group D with extra-intestinal infections in humans [54]. ST69 has been also identified among CTX positive E. coli isolates from seagulls [53]. Three isolates, one E. coli and two isolates, identified based on their 16S rDNA similarity as a members of genera Citrobacter and Klebisiella from migratory population carried blaCTX-M-3 genes, The Klebsiella sp. isolate harbored also the blaTEM-1 gene. To the authors knowledge, there are no reports describing isolation of E. coli, Citrobacter sp. and/or Klebsiella sp. harboring CTX-M-3 type alone or in combinations with other β-lactamases from rooks. Two E. coli (32 k and 38 k) isolates from the migratory as well as one (58 k) from the resident population harbored the blaCTX-M-15 gene, which is the dominant ESBL gene in strains isolated from humans and is rarely found in animals [55][57]. CTX-M-15 isolates from this study belonged to ST90 (A), ST491 (B2) and ST131 (B2), wherefrom isolates 38 k and 58 k carried a blaOXA-1 gene as well. CTX-M-15 producing ST90 (A) E. coli variant has been detected previously from yellow legged gulls in the South of France [51], whereas ST491 (B2) has not yet been detected among wildlife. In one fecal sample of the migratory population, the currently spreading pandemic CTX-M-15-producing E. coli clone B2-O25b-ST131population was isolated. The B2-O25b-ST131 clone presents an anthropogenic zoonotic pathogen [58] with high extraintestinal virulence and is described to cause urinary infections, bacteraemia, and sepsis [58][59]. Pandemic spread of B2-O25b-ST131 has also been reflected in wildlife. This clone was isolated not only from wildlife in urban areas, as detected in E. coli harbouring the CTX-M-9 type in a feral urban brown rat (Rattus norvegicus) [60], but also in Glaucous-winged gull on the remote Commander Islands in Russia [61]. Association of IS26 and blaCTX-M-15 in isolate 32 k has been observed previously in the B2-O25b-ST131 clone [31] [62]. One cefotaxime-resistant E. coli isolate (8 k) harboring the blaTEM-15 gene belonged to ST23 (A). This type of E. coli has not been detected yet in rooks.

During this study three kind of AmpC-producing Enterobacteriaceae were isolated, plasmid mediated AmpC (pAmpC) genes in E. coli isolates, combination of pAmpC and overexpression of chromosomal AmpC, and derepressed AmpC in three Enterobacter sp. isolates. The presence of pAmpC β-lactamases have been found worldwide but are less common than ESBLs [63]. Furthermore two E. coli isolates harbored pAmpC. Among the AmpC β-lactamases, blaCMY-2 is by far the most common worldwide, which was detected in isolates from human, livestock and companion animals [47] [63]. The information on the presence of AmpC producing Enterobacteriacea in wildlife is scarce. Recently, E. coli harboring CMY-2 belonged to different phylogenetic groups and STs were isolated from wild coastline birds in Miami Beach, Florida, USA [13]. Among others, one E. coli isolate belonged to B1-ST224. E. coli isolate 47.2 k analyzed in this study belonged also to the same phylogenetic group and shared the same ST with those from USA. Based on the results obtained, three Enterobacter isolates most closely related to type strain of Enterobacter hormaechei, were detected as a derepressed AmpC mutants. Derepressed production of AmpC β-lactamase has been documented to be a predominant mechanism of extended-spectrum cephalosporin resistance in clinical isolates of Enterobacter spp. [64][66]. To the authors' knowledge there are no current reports describing the isolation of stably derepressed AmpC-producing Enterobacter isolates from wildlife. In the present study, for all E. coli isolates, the bla genes could be transferred by conjugation to both E. coli recipient strains. Additionally, the majority of non-β-lactamase genes were co-transferred. Our results indicate that the horizontal dissemination of bla genes is due to multiple plasmids, because the majority of replicon types were detected both on conjugative plasmids as well as in the wild isolates. Association of ISEcp1 and blaCTX-M was observed in all but one blaCTX-M isolates. The presence of ISEcp1 element upstream of blaCTX-M in E. coli isolates originated from wildlife has been observed previously [12]. Genotyping of the enterobacterial isolates by ERIC-PCR showed that some are genetically homogeneous. These isolates have all other characteristics in common (bla genes, in case of E. coli belonged to the same phylogenetic group and ST type, replicon combination, resistance pattern) indicating that resistances to antibiotics spread, not only due to dissemination of different β-lactamases, but also due to clonal transmission. This is probable, as they originated from rooks sharing the same habitat.

Together with the isolation of pandemic CTX-M-15-producing E. coli clone B2-O25b-ST131, the isolation of MRSA isolates, even in a low prevalence (9,4% in migratory population and none in the resident), is an important finding as there are only few reports regarding this issue. In 2012, three MRSA isolates from lesser yellowlegs (Tringa flavipes) and eastern cottontails (Sylvilagus floridanus) in Central Iowa, USA have been isolated [14]. These isolates were spa typed as t002 and t008, wherefrom t008 was PVL positive. MRSA was also detected in brown rats (Rattus norvegicus), chaffinch (Fringilla coelebs), common seals (Phoca vitulina) [67], and from a hedgehog [68] but isolates from these wild animals were MRSAs carrying the novel mecC gene. Recently, our working group also detected mecC positive MRSA isolates in wildlife, particularly in European brown hare (Lepus europaeus), European otter (Lutra lutra) and a European hedgehog (Erinaceus europaeus) [22]. Very recently, 12 out of 1342 tested wild animals from Spain (Red deer, Iberian ibex, Wild boar, Eurasian Griffon vulture) were tested MRSA positive. Among them, two isolates belonging to t127, ST1 were recovered from two wild boars [15]. MRSA isolates 3mrsak and 5mrsak MRSAs had all characteristics in common, carried SCCmec IVa, belonged to spa type t127 and ST1, were PVL positive. MRSAs belonging to SCCmec IVa, t127, ST1 are commonly isolated from humans as well as from animals [69]. From Austria, a MRSA with SCCmec IVa, t127, ST1 has been reported. Three SCCmec IVa, t127, ST1 MRSA isolates originated from a veterinary hospital, (University of Veterinary Medicine, Vienna) and caused infections in horses. Two isolates originated from horse-associated personnel. All five isolates were PVL negative [70]. Unlike reports from other European countries [69] [71] there are no studies describing the isolation of MRSA belonging to t127, ST1 from livestock in Austria. The other three PVL positive MRSA isolated during this study belonged to spa type t852 and ST22 and carried SCCmec type IVc are a variant of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15) [72]. EMRSA-15 variants occur worldwide and were isolated from humans as well as from animals [73][74]. In Europe, t852, ST 22 PVL-MRSA strains are mainly reported from North-West Europe [72] [75][76]. Interestingly, there are no reports on presence of t852 MRSA in Austria, and no entries in the Ridom spaserver database (http://spaserver.ridom.de/, Accessed 2013 August 26.). To the authors' knowledge there are no reports on presence of these MRSA variants in rooks.

Based on the significant differences recorded between the migratory and non-migratory populations, it is the authors' opinion that rooks may be good indicator species for the evaluation of environmental contamination with antibiotic resistant bacteria. Populations originating from North and Central-Russia to the Ural, travel the longest distance by migrating along the Baltic to Western Europe (Ukraine, Poland, Czech Republic, Slovakia over Germany, South- West France until North-England). Rook-flocks wintering in Vienna mostly originate from Russia, Belarus, Poland and the region North-East of the Carpathian mountains and arrive regularly every winter with the first small flocks of rooks usually being observed in the beginning of October followed by a peak in the middle of the month [19].

Insufficient degradation of antibiotics in wastewater treatment plants results in antibiotic residues entering the environment in moderate concentrations, and over time, selection pressure enhances survival of organisms bearing resistance traits [77][78]. The spread of manure containing resistant organisms onto crop fields is another path of how antibiotics or resistant bacteria can enter the environment [52]. The highly significant difference in the occurrence of antibiotic resistance between the migratory population from eastern Europe compared to the non-migratory, resident population in our study indicates that rooks may provide a sufficiently good resolution for the evaluation of environmental contamination with antibiotic resistant bacteria, especially due to their ecology, foraging behavior and differing migratory behavior.

In conclusion, our study contributes to the growing evidence that multidrug resistant members of Enterobacteriaceae as well as MRSA can be found in wildlife. The presence of pandemic isolates in wildlife emphasizes the complexity in the dissemination of antimicrobial drug resistance. Moreover, the present study confirmed that rooks might represent an important vector not only of β-lactamase producing enterobacteria including pandemic zoonotic isolates but also as a vector of MRSA.

Acknowledgments

We would like to thank Yvonne Pfeifer (Robert Koch-Institut, Wernigerode, Germany) and Hana Dobiasova (Department of Biology and Wildlife Diseases, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic) for providing recipient strains. Furthermore we thank Agnes Haymerle for statistical advice.

Author Contributions

Conceived and designed the experiments: GLS CW IL. Performed the experiments: IL KM. Analyzed the data: IL FK FH KM RR. Contributed reagents/materials/analysis tools: IL FH. Wrote the paper: IL GLS FH CW.

References

  1. 1. Pitout JD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: 159–166.
  2. 2. Guenther S, Ewers C, Wieler LH (2011) Extended-Spectrum Beta-Lactamases Producing E.coli in Wildlife, yet Another Form of Environmental Pollution? Front Microbiol doi: 10.3389/fmicb.2011.00246.
  3. 3. Wirth T, Falush D, Lan R, Colles F, Mensa P, et al. (2006) Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60: 1136–1151.
  4. 4. Silva N, Igrejas G, Figueiredo N, Gonçalves A, Radhouani H, et al. (2010) Molecular characterization of antimicrobial resistance in enterococci and Escherichia coli isolates from European wild rabbit (Oryctolagus cuniculus). Sci Total Environ 408: 4871–4876.
  5. 5. Dolejska M, Cizek A, Literak I (2007) High prevalence of antimicrobial-resistant genes and integrons in Escherichia coli isolates from Black-headed Gulls in the Czech Republic. J Appl Microbiol 103: 11–19.
  6. 6. Dolejská M, Bierosová B, Kohoutová L, Literák I, Cízek A (2009) Antibiotic-resistant Salmonella and Escherichia coli isolates with integrons and extended-spectrum beta-lactamases in surface water and sympatric black-headed gulls. J Appl Microbiol 106: 1941–1950.
  7. 7. Literák I, Vanko R, Dolejská M, Cízek A, Karpísková R (2007) Antibiotic resistant Escherichia coli and Salmonella in Russian rooks (Corvus frugilegus) wintering in the Czech Republic. Lett Appl Microbiol 45: 616–621.
  8. 8. Literak I, Dolejska M, Janoszowska D, Hrusakova J, Meissner W, et al. (2010) Antibiotic-resistant Escherichia coli bacteria, including strains with genes encoding the extended-spectrum beta-lactamase and QnrS, in waterbirds on the Baltic Sea Coast of Poland. Appl Environ Microbiol 76: 8126–8134.
  9. 9. Literak I, Dolejska M, Radimersky T, Klimes J, Friedman M, et al. (2010) Antimicrobial-resistant faecal Escherichia coli in wild mammals in central Europe: multiresistant Escherichia coli producing extended-spectrum beta-lactamases in wild boars. J Appl Microbiol 108: 1702–1711.
  10. 10. Guenther S, Grobbel M, Heidemanns K, Schlegel M, Ulrich RG, et al. (2010) First insights into antimicrobial resistance among faecal Escherichia coli isolates from small wild mammals in rural areas. Sci Total Environ 408: 3519–3522.
  11. 11. Guenther S, Grobbel M. Beutlich J, Bethe A, Friedrich ND, et al. (2010) CTX-M-15-type extended-spectrum beta-lactamases-producing Escherichia coli from wild birds in Germany. Environmental Microbiology Reports 2: 641–645.
  12. 12. Tausova D, Dolejska M, Cizek A, Hanusova L, Hrusakova J, et al. (2012) Escherichia coli with extended-spectrum β-lactamase and plasmid-mediated quinolone resistance genes in great cormorants and mallards in Central Europe. J Antimicrob Chemother 67: 1103–1107.
  13. 13. Poirel L, Potron A, De La Cuesta C, Cleary T, Nordmann P, et al. (2012) Wild coastline birds as reservoirs of broad-spectrum-β-lactamase-producing Enterobacteriaceae in Miami Beach, Florida. Antimicrob Agents Chemother 56: 2756–2758.
  14. 14. Wardyn SE, Kauffman LK, Smith TC (2012) Methicillin-resistant Staphylococcus aureus in central Iowa wildlife. J Wildl Dis 48: 1069–1073.
  15. 15. Porrero MC, Mentaberre G, Sánchez S, Fernández-Llario P, Gómez-Barrero S, et al. (2013) Methicillin resistant Staphylococcus aureus (MRSA) carriage in different free-living wild animal species in Spain. Vet J 98: 127–30.
  16. 16. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, et al. (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15(41): 19688.
  17. 17. Smith TC, Pearson N (2011) The emergence of Staphylococcus aureus ST398. Vector Borne Zoonotic Dis 11: 327–339.
  18. 18. Literak I, Micudova M, Tausova D, Cizek A, Dolejska M, et al. (2012) Plasmid-Mediated Quinolone Resistance Genes in Fecal Bacteria from Rooks Commonly Wintering Throughout Europe. Microb Drug Resist 18: 567–573.
  19. 19. Bauer EB, Fiedler W (2005) Das Kompendium der Vögel Mitteleuropas. Alles über Biologie, Gefährdung und Schutz: Das Kompendium der Vögel Mitteleuropas. 3 Bände: Alles über Biologie, Gefährdung und Schutz. 2. ed. Aula, December.
  20. 20. Clinical and Laboratory Standards Institute (2013) Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-23. CLSI, Wayne, PA, USA.
  21. 21. Heininger A, Binder M, Schmidt S, Unertl K, Botzenhart K, et al. (1999) PCR and blood culture for detection of Escherichia coli bacteremia in rats. J Clin Microbiol 37: 2479–2482.
  22. 22. Loncaric I, Kübber-Heiss A, Posautz A, Stalder GL, Hoffmann D, et al. (2013) Characterization of methicillin-resistant Staphylococcus spp. carrying the mecC gene, isolated from wildlife. J Antimicrob Chemother 68: 2222–2225.
  23. 23. Kim OS, Cho YJ, Lee K, Yoon SH, Kim M, et al. (2012) Introducing EzTaxon-e: a prokaryotic 16S rRNA Gene sequence database with phylotypes that represent uncultured species. Int J Syst Evol Microbiol 62: 716–721.
  24. 24. Sanders CC, Sanders WE, Goering RV (1982) In vitro antagonism of β-lactam antibiotics by cefoxitin. Antimicrob. Agents Chemother 21: 968–975.
  25. 25. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G (2010) Development of a set of multiplex PCR assays for the detection of genes encoding importantbeta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65: 490–5.
  26. 26. Woodford N, Fagan EJ, Ellington MJ (2006) Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 57: 154–155.
  27. 27. Dierikx CM, van Duijkeren E, Schoormans AH, van Essen-Zandbergen A, Veldman K, et al. (2012) Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses. J Antimicrob Chemother 67: 1368–1374.
  28. 28. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P (2008) Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 52: 2818–2824.
  29. 29. Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40: 2153–2162.
  30. 30. Caroff N, Espaze E, Bérard I, Richet H, Reynaud A (1999) Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production. FEMS Microbiol Lett 173: 459–465.
  31. 31. Dolejska M, Frolkova P, Florek M, Jamborova I, Purgertova M, et al. (2011) CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents. J Antimicrob Chemother 66: 2784–2790.
  32. 32. Cavaco LM, Hasman H, Xia S, Aarestrup FM (2009) qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 53: 603–608.
  33. 33. Gay K, Robicsek A, Strahilevitz J, Park CH, Jacoby G, et al. (2006) Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis 43: 297–304.
  34. 34. Wang M, Guo Q, Xu X, Wang X, Ye X, et al. (2009) New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 53: 1892–1897.
  35. 35. Yamane K, Wachino J, Suzuki S, Arakawa Y (2008) Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 524: 1564–1566.
  36. 36. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC (2006) Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50: 3953–3955.
  37. 37. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, et al. (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63: 219–228.
  38. 38. Clermont O, Christenson JK, Denamur E, Gordon DM (2013) The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environmental Microbiology Reports 5: 58–65.
  39. 39. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, et al. (2009) Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64: 274–277.
  40. 40. Loncaric I, Ruppitsch W, Licek E, Moosbeckhofer R; Busse HJ, et al. (2011) Characterization of selected Gram-negative non-fermenting bacteria isolated from honey bees (Apis mellifera carnica). Apidologie 42: 312–25.
  41. 41. Loncaric I, Brunthaler R, Spergser J (2013) Suspected goat to human transmission of methicillin-resistant Staphylococcus aureus sequence type 398. J Clin Microbiol 51: 1625–1626.
  42. 42. Strommenger B, Kettlitz C, Werner G, Witte W (2003) Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol 41: 4089–4094.
  43. 43. Shittu AO, Okon K, Adesida S, Oyedara O, Witte W, et al.. (2011) Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria. BMC Microbiol. doi: 10.1186/1471-2180-11-92.
  44. 44. Løvseth A, Loncarevic S, Berdal KG (2004) Modified multiplex PCR method for detection of pyrogenic exotoxin genes in staphylococcal isolates. J Clin Microbiol 42: 3869–3872.
  45. 45. Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin. Microbiol 38: 1008–1015.
  46. 46. R Development Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL Available: http://www.R-project.org/. Accessed 2013 September 15
  47. 47. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH (2012) Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect 18: 646–655.
  48. 48. Costa D, Poeta P, Saenz Y, Vinue L, Rojo-Bezares B, et al. (2006) Detection of Escherichia coli harbouring extended-spectrum beta-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal. J Antimicrob Chemother 58: 1311–1312.
  49. 49. Pinto L, Radhouani H, Coelho C, Martins Da Costa P, Simoes R, et al. (2010) Genetic detection of extended-spectrum beta-lactamase-containing Escherichia coli isolates from birds of prey from Serra da Estrela Natural Reserve in Portugal. Appl Environ Microbiol 76: 4118–4120.
  50. 50. Wallensten A, Hernandez J, Ardiles K, González-Acuña D, Drobni M, et al. (2011) Extended spectrum beta-lactamases detected in Escherichia coli from gulls in Stockholm, Sweden. Infect Ecol Epidemiol 1: 7030.
  51. 51. Bonnedahl J, Drobni M, Gauthier-Clerc M, Hernandez J, Granholm S, et al..(2009) Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS ONE 4: , e5958. doi: 10.1371/journal.pone.0005958.
  52. 52. Guenther S, Aschenbrenner K, Stamm I, Bethe A, Semmler T, et al. (2012) Comparable High Rates of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in Birds of Prey from Germany and Mongolia. PLoS ONE 7: e53039
  53. 53. Simoes RR, Poirel L, Da Costa PM, Nordmann P (2010) Seagulls and beaches as reservoirs for multidrug-resistant Escherichia coli. Emerg Infect Dis 16: 110–112.
  54. 54. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, et al. (1999) The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67: 546–553.
  55. 55. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, et al. (2007) CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59: 165–174.
  56. 56. Carattoli A (2008) Animal reservoirs for extended spectrum beta lactamase producers. Clin Microbiol Infect 14: 117–123.
  57. 57. Chong Y, Ito Y, Kamimura T (2011) Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Genet Evol 11: 1499–1504.
  58. 58. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273–281.
  59. 59. Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66: 1–14.
  60. 60. Guenther S, Grobbel M, Beutlich J, Guerra B, Ulrich RG, et al. (2010) Detection of pandemic B2-O25-ST131 Escherichia coli harbouring the CTX-M-9 extended-spectrum beta-lactamase type in a feral urban brown rat (Rattus norvegicus). J Antimicrob Chemother 65: 582–584.
  61. 61. Hernandez J, Bonnedahl J, Eliasson I, Wallensten A, Comstedt P, et al. (2010) Globally disseminated human pathogenic Escherichia coli of O25b-ST131 clone, harbouring blaCTX-M-15, found in glaucous-winged gull at remote Commander Islands, Russia. Environ Microbiol Rep 2: 329–332.
  62. 62. Oteo J, Orden B, Bautista V, Cuevas O, Arroyo M, et al. (2009) CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. J Antimicrob Chemother 64: 712–717.
  63. 63. Jacoby GA (2009) AmpC beta-lactamases. Clin Microbiol Rev 22: 161–182.
  64. 64. Jacobs C, Huang L, Bartowsky E, Normark S, Park JT (1994) Bacterial cell wall recycling provides cytosolic muropeptides as effectors for β-lactamse induction. EMBO J 13: 4684–4694.
  65. 65. Livermore DM (1995) β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8: 557–584.
  66. 66. Livermore DM, Brown DFJ (2001) Detection of β-lactamase-mediated resistance. J Antimicrob Chemother 48: S59–S64.
  67. 67. Paterson GK, Larsen AR, Robb A, Edwards GE, Pennycott TW, et al. (2012) The newly described mecA homologue, mecALGA251, is present in methicillin-resistant Staphylococcus aureus isolates from a diverse range of host species. J Antimicrob Chemother 67: 2809–2813.
  68. 68. Monecke S, Müller E, Schwarz S, Hotzel H, Ehricht R (2012) Rapid microarray-based identification of different mecA alleles in Staphylococci. Antimicrob Agents Chemother 56: 5547–5554.
  69. 69. Franco A, Hasman H, Iurescia M, Lorenzetti R, Stegger M, et al. (2011) Molecular characterization of spa type t127, sequence type 1 methicillin-resistant Staphylococcus aureus from pigs. J Antimicrob Chemother 66: 1231–1235.
  70. 70. Cuny C, Strommenger B, Witte W, Stanek C (2008) Clusters of infections in horses with MRSA ST1, ST254, and ST398 in a veterinary hospital. Microb Drug Resist 14: 307–310.
  71. 71. Pilla R, Castiglioni V, Gelain ME, Scanziani E, Lorenzi V (2012) Long-term study of MRSA ST1, t127 mastitis in a dairy cow. Vet Rec 170: 312.
  72. 72. Boakes E, Kearns AM, Ganner M, Perry C, Warner M, et al. (2011) Molecular diversity within clonal complex 22 methicillin-resistant Staphylococcus aureus encoding Panton-Valentine leukocidin in England and Wales. Clin Microbiol Infect 17: 140–5.
  73. 73. Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, et al. (2010) Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 7: e1000215
  74. 74. Loeffler A, Boag AK, Sung J, Lindsay JA, Guardabassi L, et al. (2005) Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK. J Antimicrob Chemother 56: 692–697.
  75. 75. Börjesson S, Matussek A, Melin S, Löfgren S, Lindgren PE (2010) Methicillin-resistant Staphylococcus aureus (MRSA) in municipal wastewater: an uncharted threat? J Appl Microbiol 108: 1244–1251.
  76. 76. Larsen AR, Stegger M, Böcher S, Sørum M, Monnet DL, et al. (2009) Emergence andcharacterization of community-associated methicillin-resistant Staphyloccocus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol 47: 73–78.
  77. 77. Kümmerer K (2009) Antibiotics in the aquatic environment–a review–part I. Chemosphere 75: 417–434.
  78. 78. Kümmerer K (2009) Antibiotics in the aquatic environment–a review–part II. Chemosphere 75: 435–441.